此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Patient-Initiated and ConTrolled Oral Refeeding (PICTOR) (PICTOR)

2019年9月24日 更新者:Max Petrov、University of Auckland, New Zealand

A Randomized Controlled Trial of Patient-Initiated and ConTrolled Oral Refeeding in Acute Pancreatitis

The first step in treating patients with acute pancreatitis is to provide pain relief and intravenous fluids to keep them comfortable. As the pain subsides and patient starts to feel better food and fluids by mouth are restarted. This is done to rest the pancreas which is the organ that has been inflamed.

In some patients when food by mouth restarts they have pain and as a consequence they have a longer stay in hospital. It is thought that patients who have little pain and are within 24 hours of admission to hospital do well if they control their own food intake. This is in contrast to the usual treatment where the treating team advise when eating should restart.

研究概览

研究类型

介入性

注册 (实际的)

56

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Auckland、新西兰
        • University of Auckland; Auckland City Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 80年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • diagnosis of acute pancreatitis
  • age > 18 years
  • written informed consent

Exclusion Criteria:

  • ongoing need for opiates
  • >96 hours after onset of symptoms
  • chronic pancreatitis
  • post-ERCP pancreatitis
  • intraoperative diagnosis
  • pregnancy
  • malignancy
  • received nutrition before randomisation

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配

武器和干预

参与者组/臂
干预/治疗
无干预:常规管理
实验性的:Patient-controlled oral refeeding
Patients will be allowed to drink and eat hospital food freely as tolerated.

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Oral food intolerance
大体时间:Participants will be followed for the duration of hospital stay, an expected average of 7 days
Participants will be followed for the duration of hospital stay, an expected average of 7 days

次要结果测量

结果测量
措施说明
大体时间
Time from admission until tolerance of oral food
大体时间:Participants will be followed for the duration of hospital stay, an expected average of 7 days
Participants will be followed for the duration of hospital stay, an expected average of 7 days
Total length of hospital stay
大体时间:Participants will be followed for the duration of hospital stay, an expected average of 7 days
Participants will be followed for the duration of hospital stay, an expected average of 7 days
Need for opiates
大体时间:Participants will be followed for the duration of hospital stay, an expected average of 7 days

Need for opiates is defined when one (or more) of the following has been administered:

  • Codeine phosphate
  • Fentanyl
  • Morphine, Sevredol, Meslon
  • Oxynorm, Oxycodone
  • Tramadol
Participants will be followed for the duration of hospital stay, an expected average of 7 days
Change in pain intensity
大体时间:Baseline and 24, 48, 72h after randomisation
Baseline and 24, 48, 72h after randomisation
Progression of acute pancreatitis severity
大体时间:Participants will be followed for the duration of hospital stay, an expected average of 7 days
To be defined according to the 2012 determinant-based classification of acute pancreatitis severity
Participants will be followed for the duration of hospital stay, an expected average of 7 days
Hospital readmission
大体时间:2 weeks after hospital discharge
2 weeks after hospital discharge
Local and systemic complications
大体时间:Participants will be followed for the duration of hospital stay, an expected average of 7 days
To be defined according to the 2012 determinant-based classification of acute pancreatitis severity
Participants will be followed for the duration of hospital stay, an expected average of 7 days
Number and type of interventions during hospital stay
大体时间:Participants will be followed for the duration of hospital stay, an expected average of 7 days
Participants will be followed for the duration of hospital stay, an expected average of 7 days
Time from admission until first flatus
大体时间:Participants will be followed for the duration of hospital stay, an expected average of 7 days
Participants will be followed for the duration of hospital stay, an expected average of 7 days
Change in blood glucose
大体时间:Baseline and 24, 48, 72h after randomisation
Baseline and 24, 48, 72h after randomisation
Change in plasma C-reactive protein
大体时间:Baseline and 24, 48, 72h after randomisation
Baseline and 24, 48, 72h after randomisation

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2013年12月1日

初级完成 (实际的)

2018年6月1日

研究完成 (实际的)

2019年6月1日

研究注册日期

首次提交

2012年11月5日

首先提交符合 QC 标准的

2012年11月13日

首次发布 (估计)

2012年11月20日

研究记录更新

最后更新发布 (实际的)

2019年9月26日

上次提交的符合 QC 标准的更新

2019年9月24日

最后验证

2019年9月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • NTX/12/06/051

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅